GLP-1 medications may quiet the brain signals behind addiction, reducing substance use disorders and overdose risk across ...

Drugs originally designed to treat diabetes and obesity are reshaping medicine in unforeseen ways. Their impact on public health is really unprecedented in modern times, perhaps only upstaged by ...

A large study found that people taking GLP-1 drugs like Ozempic for diabetes were less likely to be diagnosed with substance use disorder.

Al-Aly and his colleagues found that people starting the GLP-1 drugs had lower risks of developing addiction to multiple ...

A popular class of drugs for treating diabetes and obesity reduces addiction, including abuse of alcohol, tobacco, cannabis, opioids and cocaine, according to research published March 4 by researchers ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

Drug addiction carries an extremely high risk of relapse, as cravings can be reignited by minor stimuli even long after one has stopped using. Previously, this phenomenon was attributed to a decline ...

As the nation’s director of drug control policy, James Carroll says “one thing is clear” when it comes to dealing with what he describes as the nation’s “unprecedented crisis” of drug addiction.

First-person stories of drug addiction, hope, healing, and recovery. Addiction is a complex and often misunderstood condition. This gripping special provides raw, unfiltered access to first-person ...

Lev Facher covers the U.S. addiction and overdose crisis. Drug policy was largely a backburner issue in 2025. Despite the ambitions of some moderate or right-leaning activists, and an apparent passion ...

When considering the drugs most likely to cause former addicts to repeatedly relapse, opioids, cocaine, and methamphetamine ...